Critique of "Dramatical Response to Low Dose Ultra-Slow Infusion of Alteplase for Massive Mitral Mechanical Valve Thrombosis"

Anatol J Cardiol. 2022 Oct;26(10):794-795. doi: 10.5152/AnatolJCardiol.2022.2067.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Fibrinolytic Agents / therapeutic use
  • Heart Valve Prosthesis*
  • Humans
  • Mitral Valve
  • Thrombolytic Therapy
  • Thrombosis* / diagnostic imaging
  • Thrombosis* / drug therapy
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator